Please login to the form below
Novo spends $800m to buy biotech and 'glucose responsive insulin' tech
Ziylo could help it stay ahead in key insulin franchise
Daily Brief: Biosimilar Herceptin can't make Perjeta cost effective and more
E-cigarettes can save lives - Teva gains approval for EpiPen generic
Armoured CAR ‘could overwhelm solid tumour resistance’
Eureka Therapeutics and Memorial Sloan Kettering approach shows promise
Regeneron and Teva close gap on rivals with NGF pain drug
Fasinumab was associated with less pain and improved functional ability compared to placebo
Burson Cohn & Wolfe acquires Hirshorn Zuckerman
And CEO Zuckerman will become COO
Pfizer signs mRNA flu vaccine deal with BioNTech
Pharma giant will take on development and commercial responsibility for candidates
Daily Brief: Summit's $12m lifeline, Biohaven's speech anxiety pill, Crescendo's Humabody progress
News from pharma, biotech and healthcare
Daily Brief: another departure at Gilead, veteran researcher to head up Karuna
Exodus continues from Gilead
Realm toppled by second mid-stage trial flop
The hypochlorous acid gel failed to show EASI score improvement compared to placebo
The shifting healthcare landscape
-
The power of pharma businesses to drive social changeThe importance of CSR programmes
-
The new basics Innovative products and creative marketing won’t help if our industry fails to address the new basics
-
Your excellent marketing team: let the world know about itDeadline of 30 August for PMEA awards fast approaching
-
ViiV chalks up another win for two-drug HIV regimenOnce a month injection matches triple oral therapy
-
Shock as NICE turns down Biogen’s SMA therapyUK’s cost effectiveness watchdog says the drug’s long-term benefits are unclear
-
Paramount Recruitment reveals Communiqué Casino winnersBayer’s Chris Henry and Edelman’s Nilüfer Münür win the prizes
-
Daily Brief: DeepMind and NHS success in AI, Bayer invests in COPD, Alecensa OK in Scotland The latest from pharma, biotech and healthcare
-
After Cohen payment scandal, Novartis unveils new ethics chiefNew 'risk and compliance' leader has increased powers
-
AI company Sensyne raises £60m in IPOUniversity of Oxford-developed tech powers health-focused company
Latest appointments
-
Healthcare Comms appointmentsAndrew Martello joins imc, bmore adds to team and ARK gets a new director
-
Industry appointmentsVivaldi heads up Sigilon, Pfizer Oncology loses its CMO and Zelluna appoints new CSO
-
Healthcare Comms appointmentsCuttsy+Cuttsy appoints new director, Porterhouse Medical adds to team and TBWA\WorldHealth London sees Andy Hayley and Dick Dunford return
-
Pharma industry appointmentsDestiny Pharma, Silence Therapeutics and Concept Life Sciences add to its teams.
-
Healthcare comms appointmentsLucid Group, Wilmington Healthcare and Galliard Healthcare add to their teams
Featured jobs
- Freelance Senior Account Manager – healthcare advertising
-
Employment Type:. Healthcare Advertising Jobs. Salary:. 250 to 320 per day
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- Multi-Channel Account Managers - Road / Homebased – Full or Part...
-
starting from £32, 500
-
Scientific Director
-
Great salary and bebefits
- Senior Project Manager - Medical Writing
-
Great salary and bebefits
- Senior Account Manager / Account Director
-
Great salary and bebefits
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
-
Medical Director
-
Excellent benefits
-
Market Access Consultant - Cheshire
-
Negotiable
-
Senior Medical Writer
-
Great salary and benefits
- Account Director or Senior Account Director
-
Salary TBC
-
Senior Medical Writer
-
Great salary and bebefits
-
Account Manager
-
£40, 000 - £45, 000 benefits
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
Subscribe to our email news alerts
- How can pharma engage with key stakeholders on NHS service transformation?
- The race for an HIV ‘cure’
- Medopad: the up and coming unicorn transforming remote patient monitoring
- Novo spends $800m to buy biotech and 'glucose responsive insulin' tech
- Daily Brief: Biosimilar Herceptin can't make Perjeta cost effective and more
- Armoured CAR ‘could overwhelm solid tumour resistance’
PMHub
Dovetail
We're award-winning joint working specialists. We help our clients to transform healthcare through effective collaboration, and deliver work to feel...
Latest intelligence
- How can pharma engage with key stakeholders on NHS service transformation?
- Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
- The race for an HIV ‘cure’
- Supercharging therapies as pharma and patients work together...
- Medopad: the up and coming unicorn transforming remote patient monitoring
- Blue Latitude Health speaks to Medopad’s Martha Carruthers to learn how the start-up’s modular apps are helping patients with complex diseases....
Quick links
Infographics
